Rare Diseases Public Workshop
The Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) is sponsoring a public workshop on rare disease advocacy on Monday, October 30, 2017. This public workshop builds upon previous CDER patient advocacy public workshops and is primarily for rare disease community members to help them effectively understand FDA's requirements for drug development. This workshop will include case studies demonstrating beneficial interactions of effective advocacy techniques and FDA regulatory approaches to rare disease drug development. There is no registration fee to attend. Early registration is recommended due to limited seating.